Moderna

+$7.96 (+2.30%) Today
+$1.15 (+0.33%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

CEO
Stéphane Bancel
Employees
1,300
Headquarters
Cambridge, Massachusetts
Founded
2010

MRNA Key Statistics

Market Cap
141.98B
Price-Earnings Ratio
281.98
Dividend Yield
—
Average Volume
30.45M
High Today
$359.88
Low Today
$342.28
Open Price
$346.90
Volume
11.35M
52 Week High
$362.00
52 Week Low
$54.21

MRNA News

BenzingaJul 30

Unusual Options Activity Insight: Moderna - Moderna

Shares of Moderna (NASDAQ:MRNA) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved up to $355.06. Sentiment
Yahoo FinanceJul 29

AMD CEO on chip shortage: things will improve

Motley Fool For each of the following three ultra-popular stocks, the lowest price target from an analyst on Wall Street implies downside ranging from 50% to a
BenzingaJul 27

Why Moderna Shares Dipped On Tuesday - Moderna

Moderna (NASDAQ:MRNA) shares are trading lower on reports suggesting the company is having supply issues. According to a Reuters report, the company said that

MRNA Earnings

-$0.69
$0.49
$1.66
$2.84
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure